As MGST1 inhibition is a valuable way to overcome ferroptosis resistance in vitro and in vivo, this approach can represent an experimental basis for MGST1-mediated ferroptosis resistance, exploiting it as a potential target for cancer treatment. Here, MGST1 is linked to cancer.